Medical Oncologists, Radiation Oncologists, Radiologist, Pathologists, Nuclear Medicine Physicians, Radiation Therapists, Thoracic Surgeons, Respirologists, Nurses, and Residents.
At the end of this activity, participants will be able to:
- Recognize the role of immunotherapy in non- small cell lung cancer.
- Identify the management of esophageal cancer.
- Examine the supportive care (including nutrition and hydration) in management of thoracic cancer.
- Update on COVID-19 impact in thoracic cancer management.
- Describe public health issues in thoracic cancer.
- Discuss management in stage III lung cancer post chemoradiation and immunotherapy.
McMaster University, Continuing Professional Development Program (CPD) is fully accredited by the Committee on Accreditation of Continuing Medical Education (CACME) to provide CFPC Mainpro+ and RCPSC Maintenance of Certification (MOC) study credits for Continuing Medical Education.
This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by McMaster University Continuing Professional Development Program. You may claim a maximum of 8.0 MOC Section 1 hours (credits are automatically calculated).
Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at ama–assn.org/go/internationalcme
Each healthcare provider should claim only those hours of credit that he/ she actually spent in the educational activity.